I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Newly approved and forthcoming T-cell-redirecting bispecifi..:
Granger, Katelynn
;
Gaffney, Kelly J
;
Davis, James A
Journal of Oncology Pharmacy Practice. 29 (2023) 3 - p. 722-726 , 2023
Link:
https://doi.org/10.1177/10781552231154809
RT Journal T1
Newly approved and forthcoming T-cell-redirecting bispecific antibodies for the treatment of relapsed/refractory multiple myeloma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1177_10781552231154809&Exemplar=1&LAN=DE A1 Granger, Katelynn A1 Gaffney, Kelly J A1 Davis, James A PB SAGE Publications YR 2023 SN 1078-1552 SN 1477-092X JF Journal of Oncology Pharmacy Practice VO 29 IS 3 SP 722 OP 726 LK http://dx.doi.org/https://doi.org/10.1177/10781552231154809 DO https://doi.org/10.1177/10781552231154809 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)